Maorecte 0.5 mg (Rasagiline Mesylate)

Adult dose

This medicine is administered orally once daily to adults as monotherapy or adjunctive therapy. 1) Monotherapy or adjunctive therapy to a dopamine agonist: Administer 1 mg orally once daily. 2) Adjunctive therapy to levodopa: The recommended initial dose for patients taking levodopa is 0.5 mg once daily. If the dose is well tolerated but the clinical response is inadequate, it may be increased to 1 mg once daily. This medicine may be taken with or without food.

This medication should not be taken by individuals who are allergic to the active ingredient or other components of this medication. It may be dangerous for individuals who are currently taking other MAO inhibitors or certain herbal medicines, or who have discontinued them within the last two weeks, to use this medication. Particularly, it should not be taken if the individual has taken or recently stopped medications such as pethidine, tramadol, or dextromethorphan. Patients with moderate or severe liver impairment should not take this medication, and those with slight liver impairment should proceed with caution. Various side effects may occur during the use of this medication, including headaches, dizziness, nausea, insomnia, musculoskeletal pain, and skin rashes, so the patient should consult healthcare professionals if unusual symptoms arise. This medication is used to treat Parkinson's disease and may cause impulse control disorders, drowsiness, or sudden sleep occurrences due to dopamine-related side effects, so caution is advised. During the use of this medication, one should be particularly careful when driving or operating hazardous machinery, and should avoid such activities if experiencing drowsiness or symptoms of sleep attacks. This medication can interact with various drugs, so if you are taking other medications, it is essential to inform your healthcare provider. Particularly, taking it alongside antidepressants, sympathomimetics, or certain pain relievers can lead to serious side effects, so caution is necessary. Women who are pregnant or nursing should exercise caution while taking this medication, and safety has not been established for pediatric patients or adolescents under 18. Severe side effects may occur in case of overdose, so prescribed dosages should be strictly followed and stored out of reach of children. Storage temperature should be maintained between 1–25 degrees Celsius, and transferring to another container should be avoided.

Influenza

This medication should be kept in a tightly sealed container to protect it from air and moisture. It is also recommended to store it in a cool temperature between 1 and 25 degrees Celsius.

Appearance

Flat, round tablets with edges that are white or almost white

Package unit

30 tablets/bottle